RetiSpec

Noninvasive Eye Scan to Detect Alzheimer's Disease

Health Tech & Life Sciences
Active
Series A Ramat Gan, Israel Founded 2016
Last updated 2026-06-18
Total raised
$13.6M
Last: 2024-07
Stage
Series A
Founded
2016
Headcount
32
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

RetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer's disease biomarkers in the eye. The company's goal is to enable the widespread early detection of Alzheimer's disease through accessible and scalable screening. Through a quick eye exam, RetiSpec opens a window of opportunity for timely and specific therapeutic interventions so that the progression of the disease can be slowed or even prevented. The company's patented technology harnesses hyperspectral imagery in synergy with machine learning to allow for rapid, simple, and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms. RetiSpec uses computer vision and machine-learning algorithms to detect the unique signatures of Alzheimer's biomarkers in seconds.

Funding history · 5 rounds · $13.6M total

2023-04
Grant $500K
2023-03
2020-05
Undisclosed

Q&A

What is RetiSpec's primary focus?
RetiSpec is a medical imaging company developing a noninvasive eye scan tool for the early detection of Alzheimer's disease biomarkers.
When was RetiSpec founded?
RetiSpec was founded in June 2016.
How many employees does RetiSpec have?
RetiSpec has 32 employees, falling within the 11-50 employee bucket.
What is RetiSpec's total funding to date?
RetiSpec has raised a total of $13,550,000 USD.
When was RetiSpec's most recent funding round and who were the lead investors?
RetiSpec's most recent funding round occurred in July 2024, raising $10,000,000 USD. iGan Partners and Gentex Corporation were among the investors.
Which technologies does RetiSpec utilize in its product?
RetiSpec utilizes Artificial Intelligence, Image Recognition, and Machine Learning in its technology.
Does RetiSpec hold any patents?
Yes, RetiSpec holds one patent for its technology.
Who is a co-founder and COO of RetiSpec?
Roy Kirshon is a Co-founder and COO of RetiSpec.

Team · 1

Founder · Co-founder & COO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceImage RecognitionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

imagingmachine-learningearly-detectioncomputer-visiondigital-healthcareneurologyalzheimers-diseasenon-invasivediagnosticsbiomarkers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteretispec.com
LinkedInlinkedin.com/company/17875841

Identifiers & details

Founded2016-6
Employees (exact)32
OfficesToronto

Radar intelligence

Patents

EPO6

Publications (Crossref)

Works3

Web history (Wayback)

Domainretispec.com

Certificate / subdomain footprint

Subdomains2